Research Index

Alpha-1 Antitrypsin Peptide (VIRIP) Research Index

PSI surfaces 50 peer-reviewed studies on Alpha-1 Antitrypsin Peptide (VIRIP), prioritized by evidence strength: human clinical research first, then animal studies. The full historical archive is linked below on PubMed.

Sort
Type
Condition

50 studies

High Expression of Follistatin is a Risk Factor Predicting Poor Overall Survival in Hepatocellular Carcinoma Patients.

Dai Y, Pan B, Zhao J et al.

J Hepatocell Carcinoma·2026·Human·PubMed →

Dysregulation of adipokines in the serum of breast cancer patients - role in pathogenesis and potential clinical application (preliminary studies).

Morawiec ML, Wendlocha D, Kabut J et al.

Front Immunol·2026·Human·PubMed →

Leptin/Adiponectin Ratio as a new multidimensional biomarker in obese patients with liver steatosis undergoing VLEKT: results from a pilot study.

Balestra F, Donghia R, De Luca M et al.

Front Nutr·2026·Human·PubMed →

Combined resistance exercise and essential amino acid intake enhance follistatin/myostatin ratio and muscle fitness in older women: a randomized controlled trial.

Jeong D, Valentine RJ, Jeong H et al.

J Int Soc Sports Nutr·2026·Human·Muscle Recovery, Anti-Inflammatory·PubMed →

Higher serum follistatin levels are associated with increased vascular calcification in haemodialysis patients.

Liu C, Zhang A, Li Z

Front Endocrinol (Lausanne)·2026·Human·PubMed →

Adipo-Myokine Modulation in Obesity: Integrative Effects of Spinach Thylakoids and Functional Training in Men with Obesity: A Randomized Controlled Clinical Trial.

Razi O, Shafei A, Abdi M et al.

Nutrients·2026·Human·Weight Loss, Glycemic Control·PubMed →

Lorcaserin induces abdominal fat loss with associated improvements of the circulating metabolome/lipidome and no changes in the myostatin-activin-follistatin-IGF-1 axes: A 6-month long randomized placebo-controlled clinical trial.

Ramirez-Cisneros A, Gutierrez de Piñeres V, Tamayo-Torres CS et al.

Diabetes Obes Metab·2026·Human·Weight Loss, GH Activity·PubMed →

Effects of liraglutide treatment for 35-days on total and regional fat free, lean, and bone mass, and on the Myostatin-Activin-Follistatin-IGF-1 axes: a secondary analysis of a randomized placebo-controlled crossover study.

Gutierrez de Piñeres V, Ramirez-Cisneros A, Tamayo-Torres CS et al.

Diabetes Res Clin Pract·2026·Human·Weight Loss, GH Activity, Bone Healing·PubMed →

Effects of liraglutide treatment for 18 days on metabolic parameters, regional body composition and the myostatin-activin-follistatin-IGF-1 axis: Results from an exploratory, randomized, placebo-controlled, crossover study.

Gutierrez de Piñeres V, Tamayo-Torres CS, Ramirez-Cisneros A et al.

Diabetes Obes Metab·2026·Human·Glycemic Control, GH Activity·PubMed →

miR-769-5p inhibits cellular behaviors associated with endometriosis progression by directly targeting follistatin in vitro.

Meng Y, Chen Q, Lu H

Nucleosides Nucleotides Nucleic Acids·2026·Animal·PubMed →

Detection of Activin A and Follistatin as Potential Biomarkers in Women with Ovarian Endometriosis.

Makki NF, Kadhum SH

J Steroid Biochem Mol Biol·2026·Animal·PubMed →

FSTL3-Driven Cuproptosis Resistance and EPCs Promote OSCC Metastasis.

Li SR, Wu ZZ, Wang WD et al.

J Dent Res·2026·Animal·PubMed →

Molecular and endocrine differences in early miscarriage associated with KIR polymorphisms in European ancestry women.

Cuadrado-Torroglosa I, Palomar A, Quiñonero A et al.

Reprod Biomed Online·2026·Animal·PubMed →

Screening performance of a lifestyle-based questionnaire score for vitamin D deficiency and related functional and physiological characteristics in older women.

Jeong H, Jeong D, Kang S

Phys Act Nutr·2026·Animal·PubMed →

Piezo1-Fstl1 Axis in Fracture Healing: Modulation of the Chondrocyte Inflammation-ROS-Mitochondrial Damage Cascade and Application of Smart Delivery System.

Zhang T, Wang H, Hou G et al.

Int J Biol Sci·2026·Animal·Anti-Inflammatory·PubMed →

Follistatin-like protein 1 (FSTL1) modulates bone remodeling and attenuates bone loss in a mouse model of postmenopausal osteoporosis.

Yuan H, Chen BR, Han FX et al.

JBMR Plus·2026·Animal·PubMed →

Activin A-Endothelin-1 Axis Governs Pulmonary Vascular Remodeling: Mechanistic Basis for Emerging Therapies in PAH.

Faizah NN, Ryanto GRT, Kencana SMS et al.

Arterioscler Thromb Vasc Biol·2026·Animal·PubMed →

Diagnostic Performance of Serum Adiponectin and a Biomarker-Based Model for Sarcopenia in Compensated Cirrhosis.

Boonpiraks K, Thaweesukolrat P, Surinlert P et al.

J Clin Exp Hepatol·2026·Animal·PubMed →

Endogenous targeting lipid nanoparticles for systemic mRNA delivery to lung cancer tumors.

Goo YT, Grigoriev V, Korzun T et al.

J Control Release·2026·Animal·PubMed →

The Role of Follistatin-like 1 in the Cross-Talk Among Osteoclastogenesis, Bone Marrow Stromal Cell Migration, and Osteoblastogenesis In Vitro.

Piao Y, Che X, Jin X et al.

Biomedicines·2026·Animal·PubMed →

Puerarin alleviates diabetic atherosclerosis through controlling the follistatin-like 1 related inflammation.

Chen J, Hu Z, Fang M et al.

Coron Artery Dis·2026·Animal·Cardiovascular Risk, Anti-Inflammatory·PubMed →

Cinnamaldehyde Regulates the EMT Process and Drug Resistance of Gastric Cancer Through FSTL3-Mediated Cytoskeletal Remodeling.

Zeng S, Yin Y, Zhang Y et al.

Phytother Res·2026·Animal·PubMed →

Canonical WNT signalling governs Echinococcus metacestode development.

Herrmann R, Herz M, Rudolf K et al.

PLoS Pathog·2026·Animal·PubMed →

Circulating plasma follistatin follows a 24-hour rhythm in healthy young males.

Zilstorff DB, Sennels HP, Jørgensen HL et al.

J Clin Endocrinol Metab·2026·Animal·PubMed →

[Baicalin ameliorates obesity-related lung injury by targeting FSTL1/DIP2A signaling pathway].

Cui PL, Qi BX, Wu MD et al.

Zhongguo Zhong Yao Za Zhi·2026·Animal·Weight Loss·PubMed →

Spinal cord injury-induced overflow incontinence reshapes the activin-follistatin-inhibin axis in mouse bladder and kidney.

Shen Y, Yang S, Zhou H et al.

Front Mol Biosci·2026·Animal·PubMed →

Targeted delivery of Follistatin-like 1 siRNA via biodegradable nanoparticles attenuates bleomycin-induced pulmonary fibrosis in mice.

Li X, Yao M, Yu M et al.

Exp Lung Res·2026·Animal·Tissue Remodeling·PubMed →

Multimodal characterization of sustained bioagent release from an epicardial depot for long-term biomaterial incorporation.

Varela CE, Monahan DS, Fan Y et al.

Biomaterials·2026·Animal·PubMed →

Assessing Aβ-independent effects of Module 42 on immune function in vitro.

Ajith I, Bakshi S, Mead E et al.

Alzheimers Dement·2026·Animal·PubMed →

Obese adipocytes induce fibroblast-to-myofibroblast transition through TGF-β1 signaling: implications in asthma pathogenesis.

Jalaleddine N, Hachim M, Giddey A et al.

Am J Physiol Lung Cell Mol Physiol·2026·Animal·Weight Loss, Tissue Remodeling·PubMed →

FSTL1 promotes dendritic cell pyroptosis and immunosuppression in sepsis by inhibiting STING autophagy.

Li Q, Ling H, Li J et al.

PLoS One·2026·Animal·PubMed →

Circulating Activin A and Follistatin-like Proteins in Rheumatoid Arthritis with Interstitial Lung Disease: A Cross-Sectional Comparative Study.

Ulutaş F, Kaya K, Yiğit N et al.

Diagnostics (Basel)·2026·Animal·PubMed →

Polygonatum cyrtonema Hua fructan ameliorates ulcerative colitis via gut microbiota modulation and follistatin targeting.

Xu Q, Lv Q, Yang Z et al.

NPJ Sci Food·2026·Animal·PubMed →

Serum FSTL-1 and AI-assessed muscle parameters in cancer-related malnutrition.

de Luis D, Primo D, Izaola O et al.

Nutrition·2026·Animal·Muscle Recovery·PubMed →

FSTL1 contribute to aggressive clinical behavior in DLBCL may by activating the DIP2A/ICAM-1-mediated adhesion mechanism.

Liang X, Zhang X, Wang C et al.

Biomed Pharmacother·2026·Animal·PubMed →

Cardiac rehabilitation influences serum myokine levels in patients after acute coronary syndrome: the randomised CARDIO-REH study.

Skrypnik D, Skrypnik K, Granell JC et al.

Sci Rep·2025·Human·PubMed →

The Role of Selected Myokines in the Development of Cardiovascular Diseases, and Their Involvement in Developing Heart Failure in Rheumatoid Arthritis Patients.

Kuna J, Chmielewski G, Jaśkiewicz Ł et al.

Int J Mol Sci·2025·Human·Cardiovascular Risk, Anti-Inflammatory·PubMed →

Plasma FSTL-1 as a noninvasive diagnostic biomarker for patients with advanced liver fibrosis.

Li W, Chi Y, Xiao X et al.

Hepatology·2025·Human·Liver Protection·PubMed →

Dynamic changes of systemic and local myokines in burn patients undergoing physiotherapy: A pilot prospective study.

Svecova M, Bakalar B, Vyklicka K et al.

Burns·2025·Human·Wound Healing, Muscle Recovery·PubMed →

Exploratory unsupervised machine learning of angiogenesis biomarkers in a phase II advanced cervical cancer trial of radiochemotherapy with or without neoadjuvant chemotherapy.

Arai RJ, da Costa TR, Bonadio RC et al.

Clinics (Sao Paulo)·2025·Human·PubMed →

FST Polymorphisms Associate with Musculoskeletal Traits and Modulate Exercise Response Differentially by Sex and Modality in Northern Han Chinese Adults.

Cao W, Gu Z, Fu R et al.

Genes (Basel)·2025·Human·Muscle Recovery·PubMed →

Changes in serum myostatin levels among patients with type C liver cirrhosis treated with direct-acting antivirals.

Suehiro T, Kozuru H, Matusmoto K et al.

Hepatol Res·2025·Human·PubMed →

Effects of 12-week whole-body vibration training versus resistance training in older people with sarcopenia.

Zhuang M, Gu Y, Wang Z et al.

Sci Rep·2025·Human·Muscle Recovery, Weight Loss·PubMed →

The Effect of Exercise on Spexin and Follistatin in Elderly Individuals.

Ayaz EY, Dincer B, Cinbaz G et al.

J Cachexia Sarcopenia Muscle·2025·Human·PubMed →

A first-in-human study of JNJ-70218902, a bispecific T-cell-redirecting antibody against TMEFF2 in metastatic castration-resistant prostate cancer.

Calvo E, Doger B, Carles J et al.

Oncologist·2025·Human·Immune Modulation·PubMed →

Effects of Resistance Training on Muscular Adaptations and Inflammatory Markers in Overweight and Obese Men.

Bagheri N, Bagheri R, Mesinovic J et al.

Med Sci Sports Exerc·2025·Human·Anti-Inflammatory, Muscle Recovery, Weight Loss·PubMed →

Pasteurized Akkermansia muciniphila HB05 (HB05P) Improves Muscle Strength and Function: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Kang CH, Jung ES, Jung SJ et al.

Nutrients·2024·Human·Muscle Recovery·PubMed →

Effectiveness of low-load resistance training with blood flow restriction vs. conventional high-intensity resistance training in older people diagnosed with sarcopenia: a randomized controlled trial.

Zhang M, Song Y, Zhu J et al.

Sci Rep·2024·Human·Muscle Recovery·PubMed →

Supplementing With Which Form of Creatine (Hydrochloride or Monohydrate) Alongside Resistance Training Can Have More Impacts on Anabolic/Catabolic Hormones, Strength and Body Composition?

Eghbali E, Arazi H, Suzuki K

Physiol Res·2024·Human·GH Activity, Muscle Recovery·PubMed →

Exploring the Impact of Astaxanthin Supplementation in Conjunction with a 12-Week CrossFit Training Regimen on Selected Adipo-Myokines Levels in Obese Males.

Moqaddam MA, Nemati M, Dara MM et al.

Nutrients·2024·Human·Weight Loss, Glycemic Control·PubMed →